Somatosensory Evoked Potential (SSEP) Monitoring for Detection of Intraoperative Positional Neuropraxia
Clinical Assessment of a Novel Automated SSEP Monitor for Detection and Management of Intraoperative Positional Neuropraxia
1 other identifier
observational
100
1 country
1
Brief Summary
PNI (Peripheral Nerve Injury) occurs in 5-15% of patients in cardiac surgery. So far, the mechanism of injury has never been researched. In this study, we will compare minimally invasive cardiac surgery with conventional cardiac surgery using a novel portable SSEP device to pinpoint the mechanism and timing of PNI during cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2017
CompletedFirst Submitted
Initial submission to the registry
January 29, 2018
CompletedFirst Posted
Study publicly available on registry
February 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedMarch 12, 2018
January 1, 2018
1.1 years
January 29, 2018
March 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cumulative duration of abnormal SSEP
Defined as the amplitude reduction \>50% from baseline, Latency\>10% from baseline
From the beginning of the surgery to the end of surgery
Secondary Outcomes (2)
The incidence of postoperative peripheral neuropathy at post-operative day 2-5
Post operative day 2 to 5
The number of SSEP abnormal alarms
From the beginning of the surgery to the end of surgery
Study Arms (4)
TAVI
Transcatheter Aortic Valve Implantation
cAVR
Conventional Valve Replacement
rCABG
minimally invasive coronary artery bypass graft
cCABG
Conventional Coronary Artery Bypass Graft
Eligibility Criteria
Our inclusion criteria are all adult (age\>18 years of age) cardiac surgical patients who are undergoing the four following procedures, open AVR, TAVI, conventional CABG, robotic CABG. This 4 groups of patients represent 4 different combination of potential surgical insults- median sternotomy, Internal thoracic artery (ITA) retraction, ITA harvesting, cardiopulmonary bypass and positioning
You may qualify if:
- ●all adult (age\>18, \<95 years of age) cardiac surgical patients who are undergoing the four following procedures, open AVR, TAVI, conventional CABG, robotic CABG
You may not qualify if:
- any patients with contraindication to SSEP monitoring, which include skin burns or trauma at SSEP electrode sites
- lack of written consent
- emergency surgery
- language barrier
- fluctuating neurological signs/symptoms
- regional anesthesia (spinal, epidural, nerve block)
- CABG with radial artery harvest, combined cardiac surgeries
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
London Health Sciences Centre
London, Ontario, N6A 5A5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
John Murkin, MD
Western University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2018
First Posted
February 5, 2018
Study Start
November 20, 2017
Primary Completion
December 31, 2018
Study Completion
June 30, 2019
Last Updated
March 12, 2018
Record last verified: 2018-01